{
    "nct_id": "NCT05469347",
    "official_title": "PCSK9 and Lipid Metabolism in Sepsis (PALMS) : a Two-center, Phase 1b Randomized, Placebo-controlled, Double-blind, Clinical Trial of Alirocumab in Patients with Sepsis",
    "inclusion_criteria": "* Suspected or confirmed infection as evidenced by ordering of blood cultures and administration of at least one antimicrobial agent\n* Acute respiratory or cardiovascular organ dysfunction attributed to sepsis as evidenced by at least one of the following requirements:\n\n  * Vasopressor Requirement - Continuous infusion of norepinephrine, epinephrine, vasopressin, dopamine, phenylephrine or other vasopressor agents at any dose for greater than 1 hour and required to maintain a mean arterial pressure ≥ 65 mm Hg despite intravenous crystalloid infusion of at least 1000cc\n  * Respiratory Support Requirement - Acute hypoxemic respiratory failure defined as persistent hypoxemia requiring (1) intubation and mechanical ventilation, or (2) positive pressure ventilation via tight-fitting face mask or (3) high flow nasal cannula ≥ 45 liters per minute (LPM) flow and fraction of inspired oxygen (FiO2) ≥ 0.40\n* Anticipated or confirmed intensive care unit (ICU) admission\nHealthy volunteers allowed\nMust have minimum age of 18 Years\nMust have maximum age of 90 Years",
    "exclusion_criteria": "* Organ dysfunction present > 24 hours at time randomization\n* Limitations of care (defined as refusal of cardiovascular and respiratory support described under inclusion criteria) including \"do not intubate\" (DNI) status\n* Development of sepsis while in the hospital ( i.e not present on admission to hospital)\n* Chronic hypoxemia requiring supplemental non-invasive oxygen or home mechanical ventilation\n* Chronic cardiovascular failure requiring home mechanical hemodynamic support or home chemical hemodynamic support\n* Known allergy or known contraindication to alirocumab\n* Chronic disease/illness that, in the opinion of the site investigator, have an expected lifespan of < 30 days unrelated to current sepsis diagnosis (e.g, stage IV malignancy, neurodegenerative disease, etc.)\n* Requirement of more than 6 liters (L) nasal cannula (NC) if not receiving invasive mechanical ventilation\n* Pregnancy\n* Prisoner or incarceration\n* Current participation in another interventional pharmaceutical research study for sepsis\n* Inability or unwillingness of subject or legal surrogate/representative to give written informed consent",
    "miscellaneous_criteria": ""
}